Carbamazepine · larger labeled portfolio than Glecaprevir/Pibrentasvir
SPL labels Glecaprevir/Pibrentasvir + Carbamazepine as minor; Glecaprevir/Pibrentasvir 26 / Carbamazepine 110 in that band.
Mechanism on file: Carbamazepine can speed up how your body breaks down the hepatitis C medicine, which may lower the amount of medicine in your blood. This could make the treatment less effective at fighting the virus.
FDA SPL severity: Minor
Glecaprevir/Pibrentasvir + Carbamazepine · SPL mechanism field
Carbamazepine can speed up how your body breaks down the hepatitis C medicine, which may lower the amount of medicine in your blood. This could make the treatment less effective at fighting the virus.
Minor band excerpt · Glecaprevir/Pibrentasvir with Carbamazepine
7 DRUG INTERACTIONS Carbamazepine, efavirenz, and St. Coadministration of carbamazepine, efavirenz containing regimens, and St. Carbamazepine, phenytoin, efavirenz, and St.
Glecaprevir/Pibrentasvir · 26 minor + 38 total pairs
- Amlodipine minor
- Atorvastatin minor
- Buprenorphine minor
- Buprenorphine/Naloxone minor
Carbamazepine · 129 SPL pairs (broader portfolio than Glecaprevir/Pibrentasvir)
- Acetaminophen minor
- Acetaminophen/Oxycodone minor
- Albendazole minor
- Alprazolam minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.